LNTH stock forecast
Our latest prediction for Lantheus Holdings Inc's stock price was made on the March 20, 2024 when the stock price was at 59.18$.
In the short term (2weeks), LNTH's stock price should underperform the market by -1.47%. During that period the price should oscillate between -12.14% and +7.15%.
In the medium term (3months), LNTH's stock price should underperform the market by -8.15%. During that period the price should oscillate between -32.45% and +15.98%.
Get email alertsCreate a solid portfolio with LNTH
About Lantheus Holdings Inc
lantheus holdings, inc. (nasdaq: lnth) is the parent company of lantheus medical imaging, inc. (lmi), which is a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products. lmi provides a broad portfolio of products, which are primarily used for the diagnosis of cardiovascular diseases. lmi’s key products include the echocardiography contrast agent definity® vial for (perflutren lipid microsphere) injectable suspension; technelite® (technetium tc99m generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and xenon (xenon xe 133 gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs. the company is headquartered in north billerica, massachusetts with offices in puerto rico and canada. for more information, visit www.lantheus.com.
At the moment the company generates 1438M USD in revenues.
On its last earning announcement, the company reported a profit of 4.79$ per share.
The book value per share is 1.15$
Three months stock forecastMarch 20, 2024
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1438M | - | 364M | - | 12M | 4.79 | - | - | 69M | 1.15 | - | - | - |